Preterm DElayed Cord Clamping and Early Skin-to-Skin Contact

Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The PreDECESS trial is a prospective study where that will evaluate a new method taking care of premature infants in gestational weeks 30+0 to 34+6 at birth. The new method includes delayed cord clamping and early skin-to-skin contact with a parent. Two populations of infants with their parents will be compared. Infants taken care of in the traditional way before the new method is introduced, and infants taken care of with the new method when it is being introduced. Primary question: Does delayed cord clamping and early skin-to skin contact (SSC) lead to better bonding between parents and their infants? Secondary questions: Are there any potential adverse effects with delayed cord clamping and early skin-to skin contact (SSC)? Is there a difference in infants level of bilirubin, haemoglobin or proBNP? Is there a difference in infants growth? Is there a difference in infants neurological development? Is there a difference in infants and parents level of stress? Is there a difference in mothers production of breastmilk, frequency of breastfeeding or experience of breastfeeding? Is there a difference in parents mood? How do parents of preterm infants experience giving birth of their preterm baby before and after the introduction of the new method?

Eligibility
Participation Requirements
Sex: All
Minimum Age: 7 months
Maximum Age: 7 months
Healthy Volunteers: f
View:

• Infants born in gestational weeks 30+0-34+6 through vaginal delivery and admitted to neonatal ward in Sweden.

• Parents must be able to read Swedish.

Locations
Other Locations
Sweden
Crown Princess Victoria children´s hopsital
RECRUITING
Linköping
Contact Information
Primary
Thomas Abrahamsson, MD,PhD
thomas.abrahamsson@liu.se
+46709566815
Backup
Kari Axelsson, MD
kari.axelsson@regionostergotland.se
Time Frame
Start Date: 2022-12-12
Estimated Completion Date: 2028-12-11
Participants
Target number of participants: 126
Related Therapeutic Areas
Sponsors
Leads: Ostergotland County Council, Sweden

This content was sourced from clinicaltrials.gov